1. Home
  2. Live Updates
  3. ப்ரொஃபெஸர் அலன் தச்சு

Live Breaking News & Updates on ப்ரொஃபெஸர் அலன் தச்சு|Page 3

Stay updated with breaking news from ப்ரொஃபெஸர் அலன் தச்சு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CARMAT annonce le changement de l'heure de l'assemblée générale mixte du 12 mai 2021 qui se tiendra désormais à 14h (à huis clos)

CARMAT annonce le changement de l'heure de l'assemblée générale mixte du 12 mai 2021 qui se tiendra désormais à 14h (à huis clos)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Carmat Piat , Alain Carpentier , Dusan Oresansky Quentin , Laeson Tah , William Kate Middleton , Alize Rp Relations Press Caroline Carmagnol , European Commission , Group Therabel As Well , Centre Surgical Lannelongue , Investors Documentation General , Professor Carpentier Medical , Matra Defence , Professor Alain Carpentier , Corely Belgium Sprl , May Contain , Newcap Financial , Relations Dusan Oresansky Quentin , Prince William Kate Middleton , அலன் தச்சு , வில்லியம் கேட் மிடில்டன் , ஐரோப்பிய தரகு , ப்ரொஃபெஸர் அலன் தச்சு , இருக்கலாம் கொண்டிருக்கும் , ப்ரிந்ஸ் வில்லியம் கேட் மிடில்டன் ,

CARMAT: Annual Shareholders' Meeting of May 12, 2021 in Camera: Availability of Preparatory Documents and Procedures for Participating and Remote Voting

Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world's most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a ....

United States , France General , Alain Carpentier , Ligresti Sant , Pierre Bastid Lohas , Dusan Oresansky , Caroline Carmagnol , European Commission , Health Care , Airbus Group , Centre Chirurgical Marie Lannelongue , Regulatory News , Annual Shareholder Meeting , Investors Documentation Shareholder , Professor Carpentier , Professor Alain Carpentier , Truffle Capital , Air Liquide , French State , Pierre Bastid , Antonino Ligresti , Corely Belgium , Groupe Therabel , Des March , Executive Officer , Financial Officer ,

CARMAT Announces the Issuance of a Second Tranche of Equity Warrants Within the Framework of Its Contingent Equity Line With Kepler Cheuvreux


(0)
Regulatory News:
CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces the issuance of a second tranche of 650,000 equity warrants within the framework of the contingent equity line with Kepler Cheuvreux.
On September 27, 2018, CARMAT put in place a contingent equity line contract with Kepler Cheuvreux for a maximum amount of €25 million for a duration of 3 years.
The first tranche of 400,000 equity warrants, issued in September 2018, has, to date, enabled the Company to benefit from €9.1 million in financing within the framework of this contract. ....

United States , France General , Alain Carpentier , Ligresti Sant , Pierre Bastid Lohas , Dusan Oresansky , Kepler Cheuvreux , Caroline Carmagnol , European Commission , Health Care , Airbus Group , Centre Chirurgical Marie Lannelongue , Regulatory News , Professor Carpentier , Professor Alain Carpentier , Truffle Capital , Air Liquide , French State , Pierre Bastid , Antonino Ligresti , Corely Belgium , Groupe Therabel , Des March , Executive Officer , Financial Officer , ஒன்றுபட்டது மாநிலங்களில் ,

CARMAT Obtains a €1.4 Million Grant as Part of the Industrial Recovery Plan - Strategic Sectors Call for Projects


(2)
Regulatory News:
CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that is has obtained a €1.4 million grant as a winner of the Ministry for Industry s Industrial recovery plan Strategic sectors call for projects.
This non-dilutive financing will contribute to the CAP 23 industrialization program that aims to size the production of the Aeson heart for its commercial phase, notably by:
increasing CARMAT s production capacity on its Bois-d Arcy industrial site;
digitalizing this site; and ....

United States , Bois Darcy , France General , Alain Carpentier , Ligresti Sant , Pierre Bastid Lohas , Dusan Oresansky , Caroline Carmagnol , Ministry For Industry Industrial , European Commission , Health Care , Airbus Group , Centre Chirurgical Marie Lannelongue , Regulatory News , Chief Executive Officer , Professor Carpentier , Professor Alain Carpentier , Truffle Capital , Air Liquide , French State , Pierre Bastid , Antonino Ligresti , Corely Belgium , Groupe Therabel , Des March , Executive Officer ,

CARMAT Announces the Results of Its Capital Increase of €55.7 Million After Exercise of the Increase Option


Provided by
Business Wire
Mar 8, 2021 9:59 PM UTC
CARMAT Announces the Results of Its Capital Increase of €55.7 Million After Exercise of the Increase Option
Not for Distribution in the United States of America, Canada, Australia or Japan
Regulatory News:
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart 1, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure (the “ Company”), today announces the results of its capital increase launched on February 26, 2021 which implemented without shareholders’ preferential subscription rights by way of a public offering and with a priority subscription period, on an irreducible basis ( à titre irréductible) only, to its existing shareholders and a global offering (the “ Offering”), for an amount (including the issue ....

United States , France General , United Kingdom , Pierre Bastid , Alain Carpentier , Ligresti Sant , Pierre Bastid Lohas , Kepler Cheuvreux , Dusan Oresansky , Caroline Carmagnol , French Health Authority , European Council , Airbus Group , Centre Chirurgical Marie Lannelongue , International Private Placement , European Union , European Union Withdrawal , Hc Wainwright Co , European Investment Bank , European Parliament , Drug Administration , European Commission , Financial Services , Ladenburg Thalmann Co , Health Care , Its Capital Increase ,